Zevra therapeutics to participate at upcoming investor conferences

Celebration, fla., nov. 26, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced that neil f. mcfarlane, president and chief executive office of zevra, will participate in the following december investor events.
ZVRA Ratings Summary
ZVRA Quant Ranking